Multinnova Medical Centre, Université de Montréal, Montreal, QC, Canada.
Can J Anaesth. 2012 Sep;59(9):875-81. doi: 10.1007/s12630-012-9748-y. Epub 2012 Jul 14.
Complex regional pain syndrome (CRPS) is a chronic inflammatory pain syndrome that affects one or more extremities of the body. It is characterized by burning pain and abnormalities in the sensory, motor, and autonomic nervous systems. This review illustrates how oxidative stress and nuclear factor erythroid 2-related factor (Nrf2) activation might contribute to understanding the etiopathogenesis of CRPS.
The precise cause of CRPS remains unclear, and current treatments are not effective in many patients. The mechanism underlying CRPS may differ across patients and even within a single patient over time. Inflammatory and neuronal mechanisms have been suggested as key contributors to CRPS. Recent evidence demonstrates that oxidative stress is associated with clinical symptoms in patients with CRPS-I. Oxidative stress plays a key role in CRPS pathogenesis. The Nrf2 factor is a master regulator of the transcription of multiple antioxidants, which protects against oxidative stress and inflammation by inducing antioxidant and detoxifying genes through binding with an antioxidant response element. It has antinociceptive effects against inflammatory pain in an animal model.
This review summarises the effect of oxidative stress and mitochondrial dysfunction in the pathogenesis of CRPS. It also addresses the question of whether there is a potential role for Nrf2 (activated by pharmacological or nutritional activators) in alleviating the clinical features of CRPS or preventing its progression.
复杂区域疼痛综合征(CRPS)是一种影响身体一个或多个肢体的慢性炎症性疼痛综合征。其特征为灼痛和感觉、运动及自主神经系统的异常。本综述阐述了氧化应激和核因子红细胞 2 相关因子(Nrf2)激活如何有助于理解 CRPS 的发病机制。
CRPS 的确切病因仍不清楚,目前的治疗方法对许多患者无效。CRPS 的发病机制可能因患者而异,甚至在单个患者中随时间而变化。炎症和神经元机制被认为是 CRPS 的关键促成因素。最近的证据表明,氧化应激与 CRPS-I 患者的临床症状有关。氧化应激在 CRPS 发病机制中起关键作用。Nrf2 因子是多种抗氧化剂转录的主要调节因子,通过与抗氧化反应元件结合诱导抗氧化和解毒基因,从而保护细胞免受氧化应激和炎症的影响。它在动物模型中对炎性疼痛具有抗伤害作用。
本综述总结了氧化应激和线粒体功能障碍在 CRPS 发病机制中的作用。它还探讨了 Nrf2(通过药理学或营养激活剂激活)是否有可能缓解 CRPS 的临床特征或阻止其进展。